Clinical Trial Update: Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating SK-MS10 for acute and chronic erosive gastritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Gastritis
• Gastritis

Drugs mentioned

• SK-MS10

Snippet

Sponsor: SK Chemicals Co., Ltd. | Conditions: Erosive Gastritis | Phase 2 | Status: COMPLETED